<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Galantamine</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Galantamine">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Galantamine</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Galantamine</b>, (sold under the brand name <b>Razadyne</b> among others), is used for the treatment of cognitive decline in mild to moderate Alzheimer's disease and various other memory impairments.<span class="mw-ref" id="cite_ref-drugs_2-0"><a href="#cite_note-drugs-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-birks_3-0"><a href="#cite_note-birks-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> It is an alkaloid that has been isolated from the bulbs and flowers of <i>Galanthus caucasicus</i> (Caucasian snowdrop), <i>Galanthus woronowii</i> (Voronov's snowdrop), and some other members of the family <i>Amaryllidaceae</i>, such as <i>Narcissus</i> (daffodil), <i>Leucojum aestivum</i> (snowflake), and <i>Lycoris</i> including <i>Lycoris radiata</i> (red spider lily).<span class="mw-ref" id="cite_ref-4"><a href="#cite_note-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span>  It can also be produced synthetically.</p>

<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Galantamine</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline class="mw-default-size"><img src="../I/m/Galantamine.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Galantamine.svg.png" data-file-width="512" data-file-height="523" data-file-type="drawing" height="225" width="220"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline class="mw-default-size"><img src="../I/m/Galantamine_ball-and-stick.png" tppabs="https://ptable.com/wiki/compounds/I/m/Galantamine_ball-and-stick.png" data-file-width="1999" data-file-height="1319" data-file-type="bitmap" height="145" width="220"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Razadyne, Reminyl, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/galantamine-hydrobromide.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/galantamine-hydrobromide.html'" tppabs="https://www.drugs.com/monograph/galantamine-hydrobromide.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a699058.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a699058.html'" tppabs="https://medlineplus.gov/druginfo/meds/a699058.html" class="external text external">a699058</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span>DailyMed:<span>&nbsp;</span><span><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Razadyne  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Razadyne'" tppabs="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Razadyne" class="external text external">Razadyne</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>B1<span> </span><span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_1-0"><a href="#cite_note-Drugs.com_pregnancy-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>C (Risk not ruled out)<span> </span><span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_1-1"><a href="#cite_note-Drugs.com_pregnancy-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>N06DA04<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=N06DA04  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=N06DA04'" tppabs="https://www.whocc.no/atc_ddd_index/?code=N06DA04" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li>In<span>&nbsp;</span>general: ℞<span>&nbsp;</span>(Prescription only)</li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>80–100%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>18%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Hepatic partially CYP450:CYP2D6/3A4 substrate</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>7 hours</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Renal (95%, of which 32% unchanged), fecal (5%)</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(4a<i>S</i>,6<i>R</i>,8a<i>S</i>)-5,6,9,10,11,12-Hexahydro-3-methoxy-11-methyl-4a<i>H</i>-[1]benzofuro[3a,3,2-<i>ef</i>][2]benzazepin-6-ol</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=357-70-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=357-70-0'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=357-70-0" class="external text external">357-70-0</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/9651  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/9651'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/9651" class="external text external">9651</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6693  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6693'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6693" class="external text external">6693</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00674  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00674'" tppabs="https://www.drugbank.ca/drugs/DB00674" class="external text external">DB00674</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.9272.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.9272.html'" tppabs="http://www.chemspider.com/Chemical-Structure.9272.html" class="external text external">9272</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=0D3Q044KCA  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=0D3Q044KCA'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=0D3Q044KCA" class="external text external">0D3Q044KCA</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D04292  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D04292'" tppabs="https://www.kegg.jp/entry/D04292" class="external text external">D04292</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:42944  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:42944'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:42944" class="external text external">CHEBI:42944</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL659  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL659'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL659" class="external text external">ChEMBL659</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PDB ligand</th><td><div class="plainlist"><ul><li>GNT (<span><a href="javascript:if(confirm('https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=GNT  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=GNT'" tppabs="https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=GNT" class="external text external">PDBe</a></span>, <span><a href="javascript:if(confirm('http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=GNT&polymericType=Any  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=GNT&polymericType=Any'" tppabs="http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=GNT&polymericType=Any" class="external text external">RCSB<span>&nbsp;</span>PDB</a></span>)</li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID2045606  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID2045606'" tppabs="https://comptox.epa.gov/dashboard/DTXSID2045606" class="external text external">DTXSID2045606</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.118.289  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.118.289'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.118.289" class="external text external">100.118.289</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>17</sub><span>H</span><sub>21</sub><span>N</span><span>O</span><sub>3</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">287.359</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%28c2c1O%5BC%40H%5D4C%5BC%40%40H%5D%28O%29%2FC%3DC%5C%5BC%40%40%5D43c1c%28cc2%29CN%28C%29CC3%29C  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%28c2c1O%5BC%40H%5D4C%5BC%40%40H%5D%28O%29%2FC%3DC%5C%5BC%40%40%5D43c1c%28cc2%29CN%28C%29CC3%29C'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%28c2c1O%5BC%40H%5D4C%5BC%40%40H%5D%28O%29%2FC%3DC%5C%5BC%40%40%5D43c1c%28cc2%29CN%28C%29CC3%29C" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Melting point</th><td>126.5<span>&nbsp;</span>°C (259.7<span>&nbsp;</span>°F)</td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O(c2c1O[C@H]4C[C@@H](O)/C=C\[C@@]43c1c(cc2)CN(C)CC3)C</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14-,17-/m0/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:ASUTZQLVASHGKV-JDFRZJQESA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=461118063&page2=Galantamine  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=461118063&page2=Galantamine'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=461118063&page2=Galantamine" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>Studies of usage in modern medicine began in the <a href="Soviet_Union.htm" tppabs="https://ptable.com/wiki/compounds/A/Soviet_Union" title="Soviet Union">Soviet Union</a> in the 1950s. Galantamine was isolated for the first time from bulbs of <i>Galanthus nivalis</i> (common snowdrop) by the Bulgarian chemist D. Paskov and his team in 1956.<span class="mw-ref" id="cite_ref-5"><a href="#cite_note-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> The active ingredient was extracted, identified, and studied, in particular in relation to its acetylcholinesterase (AChE)-inhibiting properties.<span class="mw-ref" id="cite_ref-6"><a href="#cite_note-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-7"><a href="#cite_note-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> The first industrial process was developed in 1959.<span class="mw-ref" id="cite_ref-8"><a href="#cite_note-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-9"><a href="#cite_note-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> However, it was not until the 1990s when full-scale synthesis was upscaled and optimized.<span class="mw-ref" id="cite_ref-10"><a href="#cite_note-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>

<p>Since the alkaloid was isolated from a botanical source, it only had contents around 0.1%, which caused the yield to also be extremely low—in the single digits.<span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Uses_in_mythology">Uses in mythology</h2></summary>
    
<p>In Homer's <i>Odyssey</i> the god Hermes gives Odysseus a herb with "a black root, but milklike flower" called "moly", which Hermes claims will make Odysseus immune to the sorceress Circe's drugs. It is believed that moly is the snowdrop <i>Galanthus nivalis</i>, which is a source of galantamine.<span class="mw-ref" id="cite_ref-myth_12-0"><a href="#cite_note-myth-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> The descriptions of moly given by Greek physician and herbalist Dioscorides support moly's identity as <i>Galanthus nivalis</i>.<span class="mw-ref" id="cite_ref-myth_12-1"><a href="#cite_note-myth-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> It has been proposed that the drugs Circe used were an extract from <i>Datura stramonium</i> (also known as jimsonweed), which causes memory loss and delirium.<span class="mw-ref" id="cite_ref-myth_12-2"><a href="#cite_note-myth-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> This would give a basis for the snowdrop's use as an antidote, as <i>Datura stramonium</i> is anticholinergic, while galantamine is an acetylcholinesterase inhibitor.<span class="mw-ref" id="cite_ref-myth_12-3"><a href="#cite_note-myth-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<table class="infobox" style="width:22em"><caption>Galantamine</caption><tbody><tr><th colspan="2" style="text-align:center;background:#ccf;">Uses</th></tr><tr><td colspan="2" style="text-align:center">treatment of dementia caused by Alzheimer's disease<span class="mw-ref" id="cite_ref-drug_facts_galantamine_13-0"><a href="#cite_note-drug_facts_galantamine-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></td></tr><tr><th colspan="2" style="text-align:center;background:#ccf;">Who might take</th></tr><tr><td colspan="2" style="text-align:center">adults who have mild-to-moderate Alzheimer's disease as indicated by the mini–mental state examination<span class="mw-ref" id="cite_ref-drug_facts_galantamine_13-1"><a href="#cite_note-drug_facts_galantamine-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></td></tr><tr><th colspan="2" style="text-align:center;background:#ccf;">Precautions</th></tr><tr><td colspan="2" style="text-align:center">
<ul><li>give fluids – drug can cause dehydration, diarrhea, or vomiting<span class="mw-ref" id="cite_ref-drug_facts_galantamine_13-2"><a href="#cite_note-drug_facts_galantamine-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></li>
<li>watch for slow heart rate and fainting<span class="mw-ref" id="cite_ref-drug_facts_galantamine_13-3"><a href="#cite_note-drug_facts_galantamine-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></li>
<li>can cause bladder blockage<span class="mw-ref" id="cite_ref-drug_facts_galantamine_13-4"><a href="#cite_note-drug_facts_galantamine-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></li>
<li>can cause seizures<span class="mw-ref" id="cite_ref-drug_facts_galantamine_13-5"><a href="#cite_note-drug_facts_galantamine-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></li>
<li>can cause bleeding in stomach or intestines<span class="mw-ref" id="cite_ref-drug_facts_galantamine_13-6"><a href="#cite_note-drug_facts_galantamine-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></li>
<li>do not combine with other sleep aid medications<span class="mw-ref" id="cite_ref-drug_facts_galantamine_13-7"><a href="#cite_note-drug_facts_galantamine-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></li>
<li>do not combine alcohol use with this drug<span class="mw-ref" id="cite_ref-drug_facts_galantamine_13-8"><a href="#cite_note-drug_facts_galantamine-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></li>
<li>people with chronic obstructive pulmonary disease should be cautious<span class="mw-ref" id="cite_ref-drug_facts_galantamine_13-9"><a href="#cite_note-drug_facts_galantamine-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></li>
<li>people with sleep apnea should be cautious<span class="mw-ref" id="cite_ref-drug_facts_galantamine_13-10"><a href="#cite_note-drug_facts_galantamine-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></li></ul>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ccf;">Other options</th></tr><tr><td colspan="2" style="text-align:center">
<ul><li><a href="Donepezil.htm" tppabs="https://ptable.com/wiki/compounds/A/Donepezil" title="Donepezil">donepezil</a> and <a href="Rivastigmine.htm" tppabs="https://ptable.com/wiki/compounds/A/Rivastigmine" title="Rivastigmine">rivastigmine</a> are comparable drugs<span class="mw-ref" id="cite_ref-drug_facts_galantamine_13-11"><a href="#cite_note-drug_facts_galantamine-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></li>
<li>behavioral, physical, or social therapy may be useful<span class="mw-ref" id="cite_ref-drug_facts_galantamine_13-12"><a href="#cite_note-drug_facts_galantamine-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></li></ul>
</td></tr></tbody></table>

<p>Galantamine is indicated for the treatment of mild to moderate vascular dementia and Alzheimer's.<span class="mw-ref" id="cite_ref-drugs_2-1"><a href="#cite_note-drugs-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-birks_3-1"><a href="#cite_note-birks-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> In the United States, it is approved by the Food and Drug Administration as safe and effective for the treatment of mild to moderate dementia.<span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span><span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> As with other cholinesterase inhibitors, galantamine may not be effective for treating mild cognitive impairment.<span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Alzheimer's_disease">Alzheimer's disease</h3></summary>
    
<p>Alzheimer's disease is characterized by the impairment of cholinergic function.<span class="mw-ref" id="cite_ref-drugs_2-2"><a href="#cite_note-drugs-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> One hypothesis is that this impairment contributes to the cognitive deficits caused by the disease. This hypothesis forms the basis for use of galantamine as a cholinergic enhancer in the treatment of Alzheimer's.<span class="mw-ref" id="cite_ref-drugs_2-3"><a href="#cite_note-drugs-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Galantamine inhibits acetylcholinesterase, an enzyme which hydrolyzes acetylcholine.<span class="mw-ref" id="cite_ref-drugs_2-4"><a href="#cite_note-drugs-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> As a result of acetylcholinesterase inhibition, galantamine increases the availability of acetylcholine for synaptic transmission.<span class="mw-ref" id="cite_ref-neurology_17-0"><a href="#cite_note-neurology-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> Additionally, galantamine binds to the allosteric sites of nicotinic receptors, which causes a conformational change.<span class="mw-ref" id="cite_ref-springer_18-0"><a href="#cite_note-springer-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> This allosteric modulation increases the nicotinic receptor's response to acetylcholine.<span class="mw-ref" id="cite_ref-neurology_17-1"><a href="#cite_note-neurology-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> The activation of presynaptic nicotinic receptors increases the release of acetylcholine, further increasing the availability of acetylcholine.<span class="mw-ref" id="cite_ref-neurology_17-2"><a href="#cite_note-neurology-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> Galantamine's competitive inhibition of acetylcholinesterase and allosteric nicotinic modulation serves as a dual mechanism of action.<span class="mw-ref" id="cite_ref-springer_18-1"><a href="#cite_note-springer-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>

<p>To reduce the prevalence of negative side effects associated with galantamine, such as nausea and vomiting, a dose-escalation scheme may be used.<span class="mw-ref" id="cite_ref-direct_19-0"><a href="#cite_note-direct-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> The use of a dose-escalation scheme has been well accepted in countries where galantamine is used.<span class="mw-ref" id="cite_ref-direct_19-1"><a href="#cite_note-direct-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> A dose-escalation scheme for Alzheimer's treatment involves a recommended starting dosage of 4<span>&nbsp;</span>mg galantamine tablets given twice a day (8<span>&nbsp;</span>mg/day).<span class="mw-ref" id="cite_ref-drugs_2-5"><a href="#cite_note-drugs-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> After a minimum of 4 weeks, the dosage may then be increased to 8<span>&nbsp;</span>mg given twice a day (16<span>&nbsp;</span>mg/day).<span class="mw-ref" id="cite_ref-drugs_2-6"><a href="#cite_note-drugs-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> After a minimum of 4 weeks at 16<span>&nbsp;</span>mg/day, the treatment may be increased to 12<span>&nbsp;</span>mg given twice a day (24<span>&nbsp;</span>mg/day).<span class="mw-ref" id="cite_ref-drugs_2-7"><a href="#cite_note-drugs-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Dosage increases are based upon the assessment of clinical benefit as well as tolerability of the previous dosage.<span class="mw-ref" id="cite_ref-drugs_2-8"><a href="#cite_note-drugs-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> If treatment is interrupted for more than three days, the process is usually restarted, beginning at the starting dosage, and re-escalating to the current dose.<span class="mw-ref" id="cite_ref-drugs_2-9"><a href="#cite_note-drugs-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> It has been found that a dosage between 16–24<span>&nbsp;</span>mg/day is the optimal dosage.<span class="mw-ref" id="cite_ref-20"><a href="#cite_note-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Available_forms">Available forms</h3></summary>
    
<p>The product is supplied in prescription form only in twice-a-day tablets, in once-a-day extended-release capsules, and in oral solution.<span class="mw-ref" id="cite_ref-drugs_2-10"><a href="#cite_note-drugs-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    
<p>Galantamine's side effect profile was similar to that of other cholinesterase inhibitors, with gastrointestinal symptoms being the most notable and most commonly observed. One study reports higher proportions of patients treated with galantamine experiencing nausea and vomiting as opposed to the placebo group.<span class="mw-ref" id="cite_ref-direct_19-2"><a href="#cite_note-direct-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> Another study using a dose-escalation treatment has found that incidences of nausea would decrease to baseline levels soon after each increase in administered dosage.<span class="mw-ref" id="cite_ref-springer_18-2"><a href="#cite_note-springer-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> In practice, some other cholinesterase inhibitors might be better tolerated; however, a careful and gradual titration over more than three months may lead to equivalent long-term tolerability.<span class="mw-ref" id="cite_ref-21"><a href="#cite_note-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span></p>

<p>The U.S. Food and Drug Administration (FDA) and international health authorities have published an alert of galantamine based on data from two studies during the treatment for  mild cognitive impairment (MCI); higher mortality rates were seen in drug-treated patients.<span class="mw-ref" id="cite_ref-22"><a href="#cite_note-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span><span class="mw-ref" id="cite_ref-23"><a href="#cite_note-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> On April 27, 2006, FDA approved labeling changes concerning all form of galantamine preparations (liquid, regular tablets, and extended release tablets) warning of the risk of bradycardia (slow resting heart rate), and sometimes atrioventricular block, especially in predisposed persons. At the same time, the risk of syncope (fainting) seems to be increased relative to placebo. "In randomized controlled trials, bradycardia was reported more frequently in galantamine-treated patients than in placebo-treated patients, but was rarely severe and rarely led to treatment discontinuation"<span class="mw-ref" id="cite_ref-24"><a href="#cite_note-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> These side effects have not been reported in Alzheimer's Disease related studies.<span class="mw-ref" id="cite_ref-25"><a href="#cite_note-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    
<p>Galantamine's chemical structure contains a tertiary amine. At a neutral pH, this tertiary amine will often bond to a hydrogen, and appear mostly as an ammonium ion.<span class="mw-ref" id="cite_ref-drugs_2-11"><a href="#cite_note-drugs-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>

<p>Galantamine is a potent allosteric potentiating ligand of human nicotinic acetylcholine receptors (nAChRs) α<sub>4</sub>β<sub>2</sub>, α<sub>3</sub>β<sub>4</sub>, and <span class="new">α<sub>6</sub>β<sub>4</sub></span>, and chicken/mouse nAChRs α<sub>7</sub>/5-HT<sub>3</sub> in certain areas of the brain.<span class="mw-ref" id="cite_ref-drugs_2-12"><a href="#cite_note-drugs-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-metabolism_26-0"><a href="#cite_note-metabolism-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> By binding to the allosteric site of the nAChRs, a conformational change occurs which increases the receptors response to acetylcholine.<span class="mw-ref" id="cite_ref-neurology_17-3"><a href="#cite_note-neurology-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> This modulation of the nicotinic cholinergic receptors on cholinergic neurons in turn causes an increase in the amount of acetylcholine released.<span class="mw-ref" id="cite_ref-27"><a href="#cite_note-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span> Galantamine also works as a weak competitive and reversible cholinesterase inhibitor in all areas of the body.<span class="mw-ref" id="cite_ref-drugs_2-13"><a href="#cite_note-drugs-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> By inhibiting acetylcholinesterase, it increases the concentration and thereby action of <a href="Acetylcholine.htm" tppabs="https://ptable.com/wiki/compounds/A/Acetylcholine" title="Acetylcholine">acetylcholine</a> in certain parts of the brain. Galantamine's effects on nAChRs and complementary acetylcholinesterase inhibition make up a dual mechanism of action. It is hypothesized that this action might relieve some of the symptoms of Alzheimer's.</p>

<center><div class="thumb tnone"></div><div class="thumbinner" style="width:222px"><img src="../I/m/Synapse_FINISHED.png" tppabs="https://ptable.com/wiki/compounds/I/m/Synapse_FINISHED.png" data-file-width="780" data-file-height="926" data-file-type="bitmap" height="261" width="220"><div class="thumbcaption" style="text-align: left">Galantamine's dual mechanism of action</div></div></center>

<p>Galantamine in its pure form is a white powder. The atomic resolution 3D structure of the complex of galantamine and its target, acetylcholinesterase, was determined by X-ray crystallography in 1999 (PDB code: <a href="javascript:if(confirm('http://oca.weizmann.ac.il/oca-bin/ocashort?id=1DX6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://oca.weizmann.ac.il/oca-bin/ocashort?id=1DX6'" tppabs="http://oca.weizmann.ac.il/oca-bin/ocashort?id=1DX6" class="external text external">1DX6</a>; <a href="javascript:if(confirm('http://www.proteopedia.org/wiki/index.php/1dx6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.proteopedia.org/wiki/index.php/1dx6'" tppabs="http://www.proteopedia.org/wiki/index.php/1dx6" class="external text external">see complex</a>).<span class="mw-ref" id="cite_ref-28"><a href="#cite_note-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> There is no evidence that galantamine alters the course of the underlying dementing process.<span class="mw-ref" id="cite_ref-29"><a href="#cite_note-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacokinetics">Pharmacokinetics</h2></summary>
    

<p>Absorption of galantamine is rapid and complete and shows linear pharmacokinetics.  It is well absorbed with absolute oral bioavailability between 80 and 100%. It has a terminal elimination half-life of seven hours. Peak effect of inhibiting acetylcholinesterase was achieved about one hour after a single oral dose of 8<span>&nbsp;</span>mg in some healthy volunteers.</p>

<p>The coadministration of food delays the rate of galantamine absorption, but does not affect the extent of absorption.<span class="mw-ref" id="cite_ref-springer_18-3"><a href="#cite_note-springer-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>

<p>Plasma protein binding of galantamine is about 18%, which is relatively low.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Metabolism">Metabolism</h2></summary>
    

<p>Approximately 75% of a dose of galantamine is metabolised in the liver. In vitro studies have shown that Hepatic CYP2D6 and CYP3A4 are involved in galantamine metabolism. Within 24 hours of intravenous or oral administration approximately 20% of a dose of galantamine will be excreted unreacted in the urine.<span class="mw-ref" id="cite_ref-springer_18-4"><a href="#cite_note-springer-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>

<p>In humans, several metabolic pathways for galantamine exist.<span class="mw-ref" id="cite_ref-metabolism_26-1"><a href="#cite_note-metabolism-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> These pathways lead to the formation of a number of different metabolites.<span class="mw-ref" id="cite_ref-metabolism_26-2"><a href="#cite_note-metabolism-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> One of the metabolites that may result can be formed through the glucuronidation of galantamine.<span class="mw-ref" id="cite_ref-metabolism_26-3"><a href="#cite_note-metabolism-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> Additionally, galantamine may undergo oxidation or demethylation at its nitrogen atom, forming two other possible metabolites.<span class="mw-ref" id="cite_ref-metabolism_26-4"><a href="#cite_note-metabolism-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> Galantamine can undergo demethylation at its oxygen atom, forming an intermediate which can then undergo glucuronidation or sulfate conjugation.<span class="mw-ref" id="cite_ref-metabolism_26-5"><a href="#cite_note-metabolism-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> Lastly, galantamine may be oxidized and then reduced before finally undergoing demethylation or oxidation at its nitrogen atom, or demethylation and subsequent glucuronidation at its oxygen atom.<span class="mw-ref" id="cite_ref-metabolism_26-6"><a href="#cite_note-metabolism-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span></p>

<center><div class="thumb tnone"></div><div class="thumbinner" style="width:222px"><img src="../I/m/Galantamine_Metabolism.png" tppabs="https://ptable.com/wiki/compounds/I/m/Galantamine_Metabolism.png" data-file-width="2169" data-file-height="2071" data-file-type="bitmap" height="210" width="220"><div class="thumbcaption" style="text-align: left">Metabolic pathways of galantamine</div></div></center>

<p>For Razadyne ER, the once-a-day formulation, CYP2D6 poor metabolizers had drug exposures that were approximately 50% higher than for extensive metabolizers. About 7% of the population has this genetic mutation; however, because the drug is individually titrated to tolerability, no specific dosage adjustment is necessary for this population.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Drug_interactions">Drug interactions</h2></summary>
    
<p>Since galantamine in metabolized by CYP2D6 and CYP3A4, inhibiting either of these isoenzymes will increase the cholinergic effects of galantamine.<span class="mw-ref" id="cite_ref-springer_18-5"><a href="#cite_note-springer-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> Inhibiting these enzymes may lead to adverse effects.<span class="mw-ref" id="cite_ref-springer_18-6"><a href="#cite_note-springer-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> It was found that <a href="Paroxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Paroxetine" title="Paroxetine">paroxetine</a>, an inhibitor of CYP2D6, increased the bioavailability of galantamine by 40%.<span class="mw-ref" id="cite_ref-springer_18-7"><a href="#cite_note-springer-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> The CYP3A4 inhibitors ketoconazole and <a href="Erythromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Erythromycin" title="Erythromycin">erythromycin</a> increased the bioavailability of galantamine by 30% and 12%, respectively.<span class="mw-ref" id="cite_ref-springer_18-8"><a href="#cite_note-springer-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Synthesis">Synthesis</h2></summary>
    



<p>Galantamine is produced from natural resources, but also has many industrial syntheses. Companies such as Janssen, Ortho-McNeil Pharmaceutical, Sanochemia Pharmazeutika, Shire, and Takeda Pharmaceutical Company have industrial processes for synthesizing Galantamine.<span class="mw-ref" id="cite_ref-30"><a href="#cite_note-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Research">Research</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Organophosphate_poisoning">Organophosphate poisoning</h3></summary>
    
<p>The toxicity of organophosphates results primarily from their action as irreversible inhibitors of acetylcholinesterase.<span class="mw-ref" id="cite_ref-organo_31-0"><a href="#cite_note-organo-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> Inhibiting acetylcholinesterase causes an increase in acetylcholine, as the enzyme is no longer available to catalyze its breakdown.<span class="mw-ref" id="cite_ref-organo_31-1"><a href="#cite_note-organo-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> In the peripheral nervous system, acetylcholine accumulation can cause an overstimulation of muscarinic receptors followed by a desensitization of nicotinic receptors.<span class="mw-ref" id="cite_ref-organo_31-2"><a href="#cite_note-organo-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> This leads to severe skeletal muscle fasciculations (involuntary contractions).<span class="mw-ref" id="cite_ref-organo_31-3"><a href="#cite_note-organo-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> The effects on the central nervous system include anxiety, restlessness, confusion, ataxia, tremors, seizures, cardiorespiratory paralysis, and coma.<span class="mw-ref" id="cite_ref-organo_31-4"><a href="#cite_note-organo-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> As a reversible acetylcholinesterase inhibitor, galantamine has the potential to serve as an effective organophosphate poisoning treatment by preventing irreversible acetylcholinesterase inhibition.<span class="mw-ref" id="cite_ref-organo_31-5"><a href="#cite_note-organo-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> Additionally, galantamine has anticonvulsant properties which may make it even more desirable as an antidote.<span class="mw-ref" id="cite_ref-organo_31-6"><a href="#cite_note-organo-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></p>

<p>Research supported in part by the US Army has led to a US patent application for the use of galantamine and/or its derivatives for treatment of organophosphate poisoning.<span class="mw-ref" id="cite_ref-organo_31-7"><a href="#cite_note-organo-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> The indications for use of galantamine in the patent application include poisoning by nerve agents "including but not limited to <a href="Soman.htm" tppabs="https://ptable.com/wiki/compounds/A/Soman" title="Soman">soman</a>, <a href="Sarin.htm" tppabs="https://ptable.com/wiki/compounds/A/Sarin" title="Sarin">sarin</a>, and VX, <a href="Tabun_(nerve_agent).htm" tppabs="https://ptable.com/wiki/compounds/A/Tabun_(nerve_agent)" title="Tabun (nerve agent)">tabun</a>, and Novichok agents".  Galantamine was studied in the research cited in the patent application for use along with the well-recognized nerve agent antidote <a href="Atropine.htm" tppabs="https://ptable.com/wiki/compounds/A/Atropine" title="Atropine">atropine</a>.  According to the investigators, an unexpected synergistic interaction occurred between galantamine and atropine in an amount of 6<span>&nbsp;</span>mg/kg or higher. Increasing the dose of galantamine from 5 to 8<span>&nbsp;</span>mg/kg decreased the dose of atropine needed to protect experimental animals from the toxicity of soman in dosages 1.5.times the dose generally required to kill half the experimental animals.<span class="mw-ref" id="cite_ref-Albuquerque_patent_32-0"><a href="#cite_note-Albuquerque_patent-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Autism">Autism</h3></summary>
    
<p>Galantamine given in addition to <a href="Risperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Risperidone" title="Risperidone">risperidone</a> to autistic children has been shown to improve some of the symptoms of autism such as irritability, lethargy, and social withdrawal.<span class="mw-ref" id="cite_ref-33"><a href="#cite_note-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span> Additionally, the cholinergic and nicotinic receptors are believed to play a role in attentional processes.<span class="mw-ref" id="cite_ref-aut_34-0"><a href="#cite_note-aut-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span> Some studies have noted that cholinergic and nicotinic treatments have improved attention in autistic children.<span class="mw-ref" id="cite_ref-aut_34-1"><a href="#cite_note-aut-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span> As such, it is hypothesized that galantamine's dual action mechanism might have a similar effect in treating autistic children and adolescents.<span class="mw-ref" id="cite_ref-aut_34-2"><a href="#cite_note-aut-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Anesthesia">Anesthesia</h3></summary>
    
<p>Galantamine may have some limited use in reducing the side-effects of anesthetics <a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">ketamine</a> and <a href="Diazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Diazepam" title="Diazepam">diazepam</a>. In one study, a control group of patients were given <a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">ketamine</a> and <a href="Diazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Diazepam" title="Diazepam">diazepam</a> and underwent anesthesia and surgery.<span class="mw-ref" id="cite_ref-anesth_35-0"><a href="#cite_note-anesth-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span> The experimental group was given <a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">ketamine</a>, <a href="Diazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Diazepam" title="Diazepam">diazepam</a>, and nivalin (of which the active ingredient is galantamine).<span class="mw-ref" id="cite_ref-anesth_35-1"><a href="#cite_note-anesth-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span> The degree of drowsiness and disorientation of the two groups was then assessed 5, 10, 15, 30 and 60 minutes after surgery.<span class="mw-ref" id="cite_ref-anesth_35-2"><a href="#cite_note-anesth-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span> The group that had taken nivalin were found to be more alert 5, 10, and 15 minutes after the surgery.<span class="mw-ref" id="cite_ref-anesth_35-3"><a href="#cite_note-anesth-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Lucid_dreaming">Lucid dreaming</h3></summary>
    
<p>Though not approved by the FDA, there is interest in the recreational use of galantamine for its purported ability to induce lucid dreaming. One study has provided some limited evidence for this practice, although it is notable that its authors have financial ties to the Lucidity Institute.<span class="mw-ref" id="cite_ref-36"><a href="#cite_note-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-Drugs.com_pregnancy-1"> <span id="mw-reference-text-cite_note-Drugs.com_pregnancy-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/pregnancy/galantamine.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/pregnancy/galantamine.html'" tppabs="https://www.drugs.com/pregnancy/galantamine.html" class="external text external">"Galantamine Use During Pregnancy"</a>. <i>Drugs.com</i>. 18 February 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">24 February</span> 2020</span>.</cite></span></li><li id="cite_note-drugs-2"> <span id="mw-reference-text-cite_note-drugs-2" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/mtm/galantamine.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/mtm/galantamine.html'" tppabs="https://www.drugs.com/mtm/galantamine.html" class="external text external">"Galantamine"</a>. Drugs.com. 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">21 April</span> 2017</span>.</cite></span></li><li id="cite_note-birks-3"> <span id="mw-reference-text-cite_note-birks-3" class="mw-reference-text"><cite id="CITEREFBirks2006" class="citation journal cs1">Birks, J (2006).  Birks, Jacqueline S (ed.). "Cholinesterase inhibitors for Alzheimer's disease". <i>The Cochrane Database of Systematic Reviews</i> (1): CD005593. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD005593  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD005593'" tppabs="https://doi.org/10.1002%2F14651858.CD005593" class="external text external">10.1002/14651858.CD005593</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16437532  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16437532'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16437532" class="external text external">16437532</a>.</cite></span></li><li id="cite_note-4"> <span id="mw-reference-text-cite_note-4" class="mw-reference-text"><a href="javascript:if(confirm('http://www.nnfcc.co.uk/publications/nnfcc-project-factsheet-sustainable-production-of-the-natural-product-galanthamine-defra-nf0612  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.nnfcc.co.uk/publications/nnfcc-project-factsheet-sustainable-production-of-the-natural-product-galanthamine-defra-nf0612'" tppabs="http://www.nnfcc.co.uk/publications/nnfcc-project-factsheet-sustainable-production-of-the-natural-product-galanthamine-defra-nf0612" class="external text external">NNFCC Project Factsheet: Sustainable Production of the Natural Product Galanthamine (Defra), NF0612</a></span></li><li id="cite_note-5"> <span id="mw-reference-text-cite_note-5" class="mw-reference-text">Tewari D, Stankiewicz AM, Mocan A, Sah AN, Tzvetkov NT, Huminiecki L, Horbańczuk JO, Atanasov AG. <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pubmed/29483867  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pubmed/29483867'" tppabs="https://www.ncbi.nlm.nih.gov/pubmed/29483867" class="external text external">Ethnopharmacological Approaches for Dementia Therapy and Significance of Natural Products and Herbal Drugs.</a> Front Aging Neurosci. 2018 Feb 12;10:3. <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816049/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816049/'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816049/" class="external text external">doi: 10.3389/fnagi.2018.00003.</a></span></li><li id="cite_note-6"> <span id="mw-reference-text-cite_note-6" class="mw-reference-text"><cite id="CITEREFHeinrich2004" class="citation journal cs1">Heinrich, M. (2004). <a href="javascript:if(confirm('http://www.pharmaceutical-journal.com/pj-online-christmas-2004-snowdrops-the-heralds-of-spring-and-a-modern-drug-for-alzheimer8217s-disease/20013614.article  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.pharmaceutical-journal.com/pj-online-christmas-2004-snowdrops-the-heralds-of-spring-and-a-modern-drug-for-alzheimer8217s-disease/20013614.article'" tppabs="http://www.pharmaceutical-journal.com/pj-online-christmas-2004-snowdrops-the-heralds-of-spring-and-a-modern-drug-for-alzheimer8217s-disease/20013614.article" class="external text external">"Snowdrops: The heralds of spring and a modern drug for Alzheimer's disease"</a>. <i>Pharmaceutical Journal</i>. <b>273</b> (7330): 905–6. OCLC<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/oclc/98892008  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/oclc/98892008'" tppabs="https://www.worldcat.org/oclc/98892008" class="external text external">98892008</a>.</cite></span></li><li id="cite_note-7"> <span id="mw-reference-text-cite_note-7" class="mw-reference-text"><cite id="CITEREFMashkovskyKruglikova–Lvova1951" class="citation journal cs1">Mashkovsky, MD; Kruglikova–Lvova, RP (1951). "On the pharmacology of the new alkaloid galantamine". <i>Farmakologia Toxicologia</i>. <b>14</b>: 27–30.</cite></span></li><li id="cite_note-8"> <span id="mw-reference-text-cite_note-8" class="mw-reference-text"><cite id="CITEREFHeinrichTeoh2004" class="citation journal cs1">Heinrich, M.; Teoh, H.L. (2004). "Galanthamine from snowdrop – the development of a modern drug against Alzheimer's disease from local Caucasian knowledge". <i>Journal of Ethnopharmacology</i>. <b>92</b> (2–3): 147–162. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jep.2004.02.012  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jep.2004.02.012'" tppabs="https://doi.org/10.1016%2Fj.jep.2004.02.012" class="external text external">10.1016/j.jep.2004.02.012</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15137996  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15137996'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15137996" class="external text external">15137996</a>.</cite></span></li><li id="cite_note-9"> <span id="mw-reference-text-cite_note-9" class="mw-reference-text"><cite id="CITEREFScottGoa2000" class="citation journal cs1">Scott, LJ; Goa, KL (2000). "Galantamine: a review of its use in Alzheimer's disease". <i>Drugs</i>. <b>60</b> (5): 1095–122. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003495-200060050-00008  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003495-200060050-00008'" tppabs="https://doi.org/10.2165%2F00003495-200060050-00008" class="external text external">10.2165/00003495-200060050-00008</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11129124  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11129124'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11129124" class="external text external">11129124</a>.</cite></span></li><li id="cite_note-10"> <span id="mw-reference-text-cite_note-10" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.alzforum.org/therapeutics/galantamine  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.alzforum.org/therapeutics/galantamine'" tppabs="https://www.alzforum.org/therapeutics/galantamine" class="external text external">"Galantamine | ALZFORUM"</a>. <i>www.alzforum.org</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2019-11-17</span></span>.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text">Kim, J. K.; Park, S. U. Pharmacological aspects of galantamine for the treatment of Alzheimer's disease. <i>EXCLI journal</i> <b>2017</b>, 16, 35-39.</span></li><li id="cite_note-myth-12"> <span id="mw-reference-text-cite_note-myth-12" class="mw-reference-text"><cite id="CITEREFBlock" class="citation web cs1">Block, Will. <a href="javascript:if(confirm('http://old.life-enhancement.com/magazine/article/488-fight-alzheimers-disease  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://old.life-enhancement.com/magazine/article/488-fight-alzheimers-disease'" tppabs="http://old.life-enhancement.com/magazine/article/488-fight-alzheimers-disease" class="external text external">"Galantamine, the Odyssey's Nootropic Phytonutrient, Revives Memory and Helps Fight Alzheimer's Disease"</a>. <i>Life enhancement</i><span class="reference-accessdate">. Retrieved <span class="nowrap">19 November</span> 2019</span>.</cite></span></li><li id="cite_note-drug_facts_galantamine-13"> <span id="mw-reference-text-cite_note-drug_facts_galantamine-13" class="mw-reference-text"><cite id="CITEREFInformulary2014" class="citation web cs1">Informulary (April 2014). <a href="javascript:if(confirm('http://consumerhealthchoices.org/wp-content/uploads/2014/04/CR-DrugFactsBox-Razadyne.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://consumerhealthchoices.org/wp-content/uploads/2014/04/CR-DrugFactsBox-Razadyne.pdf'" tppabs="http://consumerhealthchoices.org/wp-content/uploads/2014/04/CR-DrugFactsBox-Razadyne.pdf" class="external text external">"Drug Facts Box: Razadyne (galantamine)"</a> <span class="cs1-format">(PDF)</span>. <i>Consumer Reports</i>. Consumer Reports<span class="reference-accessdate">. Retrieved <span class="nowrap">5 November</span> 2015</span>.</cite></span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.centerwatch.com/drug-information/fda-approved-drugs/drug/666/reminyl-galantamine-hydrobromide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.centerwatch.com/drug-information/fda-approved-drugs/drug/666/reminyl-galantamine-hydrobromide'" tppabs="https://www.centerwatch.com/drug-information/fda-approved-drugs/drug/666/reminyl-galantamine-hydrobromide" class="external text external">"Reminyl (galantamine hydrobromide)"</a>. CenterWatch. 2001<span class="reference-accessdate">. Retrieved <span class="nowrap">17 December</span> 2017</span>.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/021615lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/021615lbl.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/021615lbl.pdf" class="external text external">"Galantamine hydrobromide (trademark)"</a> <span class="cs1-format">(PDF)</span>. US Food and Drug Administration. 2004<span class="reference-accessdate">. Retrieved <span class="nowrap">17 December</span> 2017</span>.</cite></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite id="CITEREFTriccoSoobiahBerlinerHo2013" class="citation journal cs1">Tricco, A. C; Soobiah, C; Berliner, S; Ho, J. M; Ng, C. H; Ashoor, H. M; Chen, M. H; Hemmelgarn, B; Straus, S. E (2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826344  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826344'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826344" class="external text external">"Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: A systematic review and meta-analysis"</a>. <i>Canadian Medical Association Journal</i>. <b>185</b> (16): 1393–1401. doi:<a href="javascript:if(confirm('https://doi.org/10.1503%2Fcmaj.130451  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1503%2Fcmaj.130451'" tppabs="https://doi.org/10.1503%2Fcmaj.130451" class="external text external">10.1503/cmaj.130451</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826344  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826344'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826344" class="external text external">3826344</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24043661  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24043661'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24043661" class="external text external">24043661</a>.</cite></span></li><li id="cite_note-neurology-17"> <span id="mw-reference-text-cite_note-neurology-17" class="mw-reference-text"><cite id="CITEREFRaskindPeskindWesselYuan2000" class="citation journal cs1">Raskind MA, Peskind ER, Wessel T, Yuan W (June 2000). "Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group". <i>Neurology</i>. <b>54</b> (12): 2261–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1212%2Fwnl.54.12.2261  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1212%2Fwnl.54.12.2261'" tppabs="https://doi.org/10.1212%2Fwnl.54.12.2261" class="external text external">10.1212/wnl.54.12.2261</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10881250  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10881250'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10881250" class="external text external">10881250</a>.</cite></span></li><li id="cite_note-springer-18"> <span id="mw-reference-text-cite_note-springer-18" class="mw-reference-text"><cite id="CITEREFFarlow2003" class="citation journal cs1">Farlow, M.R. (2003). "Clinical Pharmacokinetics of Galantamine". <i>Clin Pharmacokinet</i>. <b>42</b> (15): 1383–92. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003088-200342150-00005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003088-200342150-00005'" tppabs="https://doi.org/10.2165%2F00003088-200342150-00005" class="external text external">10.2165/00003088-200342150-00005</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14674789  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14674789'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14674789" class="external text external">14674789</a>.</cite></span></li><li id="cite_note-direct-19"> <span id="mw-reference-text-cite_note-direct-19" class="mw-reference-text"><cite id="CITEREFErkinjunttiKurzGauthierBullock2002" class="citation journal cs1">Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Damaraju CV (April 2002). "Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial". <i>Lancet</i>. <b>359</b> (9314): 1283–90. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0140-6736%2802%2908267-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0140-6736%2802%2908267-3'" tppabs="https://doi.org/10.1016%2FS0140-6736%2802%2908267-3" class="external text external">10.1016/S0140-6736(02)08267-3</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11965273  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11965273'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11965273" class="external text external">11965273</a>.</cite></span></li><li id="cite_note-20"> <span id="mw-reference-text-cite_note-20" class="mw-reference-text">Hager, K.; Baseman, A. S.; Nye, J. S.; Brashear, H. R.; Han, J.; Sano, M.; Davis, B.; Richards, H. M. Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer's disease. <i>Neuropsychiatric disease and treatment</i> <b>2014</b>, 10, 391-401.</span></li><li id="cite_note-21"> <span id="mw-reference-text-cite_note-21" class="mw-reference-text"><cite id="CITEREFBirksBirks2006" class="citation journal cs1">Birks, J; Birks, Jacqueline (2006).  Birks, Jacqueline (ed.). "Cholinesterase inhibitors for Alzheimer's disease". <i>Cochrane Database of Systematic Reviews</i> (1): CD005593. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD005593  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD005593'" tppabs="https://doi.org/10.1002%2F14651858.CD005593" class="external text external">10.1002/14651858.CD005593</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16437532  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16437532'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16437532" class="external text external">16437532</a>.</cite></span></li><li id="cite_note-22"> <span id="mw-reference-text-cite_note-22" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm126138.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm126138.pdf'" tppabs="https://www.fda.gov/downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm126138.pdf" class="external text external">"FDA ALERT: Galantamine hydrobromide (marketed as Razadyne, formerly Reminyl) – Healthcare Professional Sheet"</a> <span class="cs1-format">(PDF)</span>. <i>Postmarket Drug Safety Information for Patients and Providers</i>. Food and Drug Administration. May 2005<span class="reference-accessdate">. Retrieved <span class="nowrap">2010-04-02</span></span>.</cite></span></li><li id="cite_note-23"> <span id="mw-reference-text-cite_note-23" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm152595.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm152595.htm'" tppabs="https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm152595.htm" class="external text external">"Safety Alerts for Human Medical Products &gt; Reminyl (galantamine hydrobromide)"</a>. <i># MedWatch The FDA Safety Information and Adverse Event Reporting Program</i>. Food and Drug Administration. March 2005<span class="reference-accessdate">. Retrieved <span class="nowrap">2010-08-04</span></span>.</cite></span></li><li id="cite_note-24"> <span id="mw-reference-text-cite_note-24" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20071009145003/https://www.fda.gov/medwatch/safety/2006/apr06.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20071009145003/https://www.fda.gov/medwatch/safety/2006/apr06.htm'" tppabs="https://web.archive.org/web/20071009145003/https://www.fda.gov/medwatch/safety/2006/apr06.htm" class="external text external">"Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)"</a>. <i>MedWatch, The FDA Safety Information and Adverse Event Reporting Program</i>. Food and Drug Administration. April 2006. Archived from <a href="javascript:if(confirm('https://www.fda.gov/medwatch/safety/2006/apr06.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/medwatch/safety/2006/apr06.htm'" tppabs="https://www.fda.gov/medwatch/safety/2006/apr06.htm" class="external text external">the original</a> on 2007-10-09<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-07-30</span></span>.</cite></span></li><li id="cite_note-25"> <span id="mw-reference-text-cite_note-25" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/prof/_2005/reminyl_hpc-eng.php  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/prof/_2005/reminyl_hpc-eng.php'" tppabs="http://hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/prof/_2005/reminyl_hpc-eng.php" class="external text external">"Safety information from Investigational Studies with REMINYL (galantamine hydrobromide) in Mild Cognitive Impairment"</a>. Janssen-Ortho Inc. 2005-04-22<span class="reference-accessdate">. Retrieved <span class="nowrap">29 August</span> 2012</span>.</cite></span></li><li id="cite_note-metabolism-26"> <span id="mw-reference-text-cite_note-metabolism-26" class="mw-reference-text"><cite id="CITEREFMannensSnelHendrickxVerhaeghe2002" class="citation journal cs1">Mannens, G. S; Snel, C. A; Hendrickx, J; Verhaeghe, T; Le Jeune, L; Bode, W; Van Beijsterveldt, L; Lavrijsen, K; Leempoels, J; Van Osselaer, N; Van Peer, A; Meuldermans, W (2002). "The metabolism and excretion of galantamine in rats, dogs, and humans". <i>Drug Metabolism and Disposition</i>. <b>30</b> (5): 553–63. doi:<a href="javascript:if(confirm('https://doi.org/10.1124%2Fdmd.30.5.553  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1124%2Fdmd.30.5.553'" tppabs="https://doi.org/10.1124%2Fdmd.30.5.553" class="external text external">10.1124/dmd.30.5.553</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11950787  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11950787'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11950787" class="external text external">11950787</a>.</cite></span></li><li id="cite_note-27"> <span id="mw-reference-text-cite_note-27" class="mw-reference-text"><cite id="CITEREFWoodruff-PakVogelWenk2001" class="citation journal cs1">Woodruff-Pak, Diana S.; Vogel, Richard W.; Wenk, Gary L. (2001). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC29386  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC29386'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC29386" class="external text external">"Galantamine: Effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning"</a>. <i>Proceedings of the National Academy of Sciences</i>. <b>98</b> (4): 2089–94. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/2001PNAS...98.2089W  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/2001PNAS...98.2089W'" tppabs="https://ui.adsabs.harvard.edu/abs/2001PNAS...98.2089W" class="external text external">2001PNAS...98.2089W</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1073%2Fpnas.031584398  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1073%2Fpnas.031584398'" tppabs="https://doi.org/10.1073%2Fpnas.031584398" class="external text external">10.1073/pnas.031584398</a>. JSTOR<span>&nbsp;</span><a href="javascript:if(confirm('https://www.jstor.org/stable/3055005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.jstor.org/stable/3055005'" tppabs="https://www.jstor.org/stable/3055005" class="external text external">3055005</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC29386  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC29386'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC29386" class="external text external">29386</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11172080  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11172080'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11172080" class="external text external">11172080</a>.</cite></span></li><li id="cite_note-28"> <span id="mw-reference-text-cite_note-28" class="mw-reference-text"><cite id="CITEREFGreenblattKrygerLewisSilman1999" class="citation journal cs1">Greenblatt, H.M.; Kryger, G.; Lewis, T.; Silman, I.; Sussman, J.L. (1999). "Structure of acetylcholinesterase complexed with (−)-galanthamine at 2.3 Å resolution". <i>FEBS Letters</i>. <b>463</b> (3): 321–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0014-5793%2899%2901637-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0014-5793%2899%2901637-3'" tppabs="https://doi.org/10.1016%2FS0014-5793%2899%2901637-3" class="external text external">10.1016/S0014-5793(99)01637-3</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10606746  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10606746'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10606746" class="external text external">10606746</a>.</cite></span></li><li id="cite_note-29"> <span id="mw-reference-text-cite_note-29" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20091222071643/http://www.ortho-mcneilneurologics.com/ortho-mcneilneurologics/shared/pi/razadyne.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20091222071643/http://www.ortho-mcneilneurologics.com/ortho-mcneilneurologics/shared/pi/razadyne.pdf'" tppabs="https://web.archive.org/web/20091222071643/http://www.ortho-mcneilneurologics.com/ortho-mcneilneurologics/shared/pi/razadyne.pdf" class="external text external">"Ortho-McNeil Neurologics, "Razadyne ER US Product Insert", May 2006"</a> <span class="cs1-format">(PDF)</span>. Archived from <a href="javascript:if(confirm('http://www.ortho-mcneilneurologics.com/ortho-mcneilneurologics/shared/pi/razadyne.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ortho-mcneilneurologics.com/ortho-mcneilneurologics/shared/pi/razadyne.pdf'" tppabs="http://www.ortho-mcneilneurologics.com/ortho-mcneilneurologics/shared/pi/razadyne.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 2009-12-22<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-12-21</span></span>.</cite></span></li><li id="cite_note-30"> <span id="mw-reference-text-cite_note-30" class="mw-reference-text"><cite id="CITEREFMucke2015" class="citation journal cs1">Mucke, Hermann AM (2015-09-03). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137937  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137937'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137937" class="external text external">"The case of galantamine: repurposing and late blooming of a cholinergic drug"</a>. <i>Future Science OA</i>. <b>1</b> (4): FSO73. doi:<a href="javascript:if(confirm('https://doi.org/10.4155%2Ffso.15.73  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4155%2Ffso.15.73'" tppabs="https://doi.org/10.4155%2Ffso.15.73" class="external text external">10.4155/fso.15.73</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/2056-5623  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/2056-5623'" tppabs="https://www.worldcat.org/issn/2056-5623" class="external text external">2056-5623</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137937  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137937'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137937" class="external text external">5137937</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28031923  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28031923'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28031923" class="external text external">28031923</a>.</cite></span></li><li id="cite_note-organo-31"> <span id="mw-reference-text-cite_note-organo-31" class="mw-reference-text"><cite id="CITEREFAlbuquerquePereiraAracavaFawcett2006" class="citation journal cs1">Albuquerque, E. X.; Pereira, E. F. R.; Aracava, Y.; Fawcett, W. P.; Oliveira, M.; Randall, W. R.; Adler, M. (2006). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550772  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550772'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550772" class="external text external">"Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i>. <b>103</b> (35): 13220–13225. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/2006PNAS..10313220A  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/2006PNAS..10313220A'" tppabs="https://ui.adsabs.harvard.edu/abs/2006PNAS..10313220A" class="external text external">2006PNAS..10313220A</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1073%2Fpnas.0605370103  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1073%2Fpnas.0605370103'" tppabs="https://doi.org/10.1073%2Fpnas.0605370103" class="external text external">10.1073/pnas.0605370103</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550772  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550772'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550772" class="external text external">1550772</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16914529  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16914529'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16914529" class="external text external">16914529</a>.</cite></span></li><li id="cite_note-Albuquerque_patent-32"> <span id="mw-reference-text-cite_note-Albuquerque_patent-32" class="mw-reference-text"><cite id="CITEREFAlbuquerque,_Edson_XAdler,_MichaelPereira,_Edna_F.R.2009" class="citation web cs1">Albuquerque, Edson X, Adler, Michael, Pereira, Edna F.R. (January 22, 2009). <a href="javascript:if(confirm('http://appft.uspto.gov/netacgi/nph-Parser?p=1&u=%2Fnetahtml%2FPTO%2Fsearch-adv.html&r=1&f=G&l=50&d=PG01&s1=20090023706.PN.&OS=PN/20090023706&RS=PN/20090023706  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://appft.uspto.gov/netacgi/nph-Parser?p=1&u=%2Fnetahtml%2FPTO%2Fsearch-adv.html&r=1&f=G&l=50&d=PG01&s1=20090023706.PN.&OS=PN/20090023706&RS=PN/20090023706'" tppabs="http://appft.uspto.gov/netacgi/nph-Parser?p=1&u=%2Fnetahtml%2FPTO%2Fsearch-adv.html&r=1&f=G&l=50&d=PG01&s1=20090023706.PN.&OS=PN/20090023706&RS=PN/20090023706" class="external text external">"United States Patent Application 20090023706"</a>. US Patent and Trademark Office<span class="reference-accessdate">. Retrieved <span class="nowrap">27 May</span> 2016</span>.</cite></span></li><li id="cite_note-33"> <span id="mw-reference-text-cite_note-33" class="mw-reference-text"><cite id="CITEREFGhaleihaGhyasvandMohammadiFarokhnia2013" class="citation journal cs1">Ghaleiha, A; Ghyasvand, M; Mohammadi, M. R.; Farokhnia, M; Yadegari, N; Tabrizi, M; Hajiaghaee, R; Yekehtaz, H; Akhondzadeh, S (2013). "Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial". <i>Journal of Psychopharmacology</i>. <b>28</b> (7): 677–685. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F0269881113508830  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F0269881113508830'" tppabs="https://doi.org/10.1177%2F0269881113508830" class="external text external">10.1177/0269881113508830</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24132248  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24132248'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24132248" class="external text external">24132248</a>.</cite></span></li><li id="cite_note-aut-34"> <span id="mw-reference-text-cite_note-aut-34" class="mw-reference-text"><cite id="CITEREFNicolsonCraven-ThussSmith2006" class="citation journal cs1">Nicolson R, Craven-Thuss B, Smith J (October 2006). "A prospective, open-label trial of galantamine in autistic disorder". <i>J Child Adolesc Psychopharmacol</i>. <b>16</b> (5): 621–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1089%2Fcap.2006.16.621  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1089%2Fcap.2006.16.621'" tppabs="https://doi.org/10.1089%2Fcap.2006.16.621" class="external text external">10.1089/cap.2006.16.621</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17069550  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17069550'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17069550" class="external text external">17069550</a>.</cite></span></li><li id="cite_note-anesth-35"> <span id="mw-reference-text-cite_note-anesth-35" class="mw-reference-text"><cite id="CITEREFChakalovaMarinovaSrebrevaAnastasov1987" class="citation journal cs1">Chakalova E, Marinova M, Srebreva M, Anastasov D, Ploskov K (1987). "[Attempt to eliminate residual somnolence and disorientation with nivaline after anesthesia with ketalar and diazepam for minor obstetrical and gynecologic surgery]". <i>Akush Ginekol (Sofiia)</i> (in Bulgarian). <b>26</b> (3): 28–31. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/3631427  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/3631427'" tppabs="https://pubmed.ncbi.nlm.nih.gov/3631427" class="external text external">3631427</a>.</cite></span></li><li id="cite_note-36"> <span id="mw-reference-text-cite_note-36" class="mw-reference-text"><cite id="CITEREFLaBerge2018" class="citation journal cs1">LaBerge (August 2018). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082533  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082533'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082533" class="external text external">"Pre-sleep treatment with galantamine stimulates lucid dreaming: A double-blind, placebo-controlled, crossover study"</a>. <i>PLOS One</i>. <b>13</b> (8): e0201246. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/2018PLoSO..1301246L  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/2018PLoSO..1301246L'" tppabs="https://ui.adsabs.harvard.edu/abs/2018PLoSO..1301246L" class="external text external">2018PLoSO..1301246L</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1371%2Fjournal.pone.0201246  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1371%2Fjournal.pone.0201246'" tppabs="https://doi.org/10.1371%2Fjournal.pone.0201246" class="external text external">10.1371/journal.pone.0201246</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082533  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082533'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082533" class="external text external">6082533</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/30089135  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/30089135'" tppabs="https://pubmed.ncbi.nlm.nih.gov/30089135" class="external text external">30089135</a>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><a href="javascript:if(confirm('https://web.archive.org/web/20150101171945/http://www.razadyneer.com/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150101171945/http://www.razadyneer.com/'" tppabs="https://web.archive.org/web/20150101171945/http://www.razadyneer.com/" class="external text external">Razadyne ER</a> (manufacturer's website)</li>
<li><i>Proteopedia <a href="javascript:if(confirm('http://www.proteopedia.org/wiki/index.php/1dx6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.proteopedia.org/wiki/index.php/1dx6'" tppabs="http://www.proteopedia.org/wiki/index.php/1dx6" class="external text external">1dx6</a></i></li>
<li><a href="javascript:if(confirm('http://proteopedia.org/wiki/index.php/AChE_inhibitors_and_substrates_%28Part_II%29  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://proteopedia.org/wiki/index.php/AChE_inhibitors_and_substrates_%28Part_II%29'" tppabs="http://proteopedia.org/wiki/index.php/AChE_inhibitors_and_substrates_%28Part_II%29" class="external text external">AChE inhibitors and substrates (Part II)</a></li>
<li><a href="javascript:if(confirm('https://web.archive.org/web/20190301095524/http://www.ebi.ac.uk/pdbe/quips?story=AChE  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20190301095524/http://www.ebi.ac.uk/pdbe/quips?story=AChE'" tppabs="https://web.archive.org/web/20190301095524/http://www.ebi.ac.uk/pdbe/quips?story=AChE" class="external text external">Acetylcholinesterase: A gorge-ous enzyme</a> PDB Structure article at <a href="javascript:if(confirm('http://www.pdbe.org/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.pdbe.org/'" tppabs="http://www.pdbe.org/" class="external text external">PDBe</a></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Psychoanaleptics:_Anti-dementia_agents_(ATC_code_N06D_and_others)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Psychoanaleptics:_Anti-dementia_agents_(ATC_code_N06D_and_others)" style="font-size:114%;margin:0 4em">Psychoanaleptics: Anti-dementia agents (ATC code N06D and others)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">AChE inhibitor medications</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Donepezil.htm" tppabs="https://ptable.com/wiki/compounds/A/Donepezil" title="Donepezil">Donepezil</a></li>
<li><a href="Galantamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Galantamine" title="Galantamine">Galantamine</a></li>
<li>Ipidacrine</li>
<li><a href="Rivastigmine.htm" tppabs="https://ptable.com/wiki/compounds/A/Rivastigmine" title="Rivastigmine">Rivastigmine</a></li>
<li><a href="Tacrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tacrine" title="Tacrine">Tacrine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other medications</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Bifemelane</li>
<li>Ginkgo folium</li>
<li>Meclofenoxate (centrophenoxine)</li>
<li><a href="Memantine.htm" tppabs="https://ptable.com/wiki/compounds/A/Memantine" title="Memantine">Memantine</a></li>
<li><a href="Nicergoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicergoline" title="Nicergoline">Nicergoline</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Experimental BACE inhibitors</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Lanabecestat</li>
<li>Verubecestat</li></ul>
</div></td></tr></tbody></table></div>

<div role="navigation" class="navbox" aria-labelledby="Acetylcholine_metabolism_and_transport_modulators" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Acetylcholine_metabolism_and_transport_modulators" style="font-size:114%;margin:0 4em"><a href="Acetylcholine.htm" tppabs="https://ptable.com/wiki/compounds/A/Acetylcholine" title="Acetylcholine">Acetylcholine</a> metabolism and transport modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Enzyme<br><small>(modulators)</small></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center;"><abbr>ChAT</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Inhibitors:</b> <span class="new">1-(-Benzoylethyl)pyridinium</span></li>
<li><span class="new">2-(α-Naphthoyl)ethyltrimethylammonium</span></li>
<li><span class="new">3-Chloro-4-stillbazole</span></li>
<li><span class="new">4-(1-Naphthylvinyl)pyridine</span></li>
<li><span class="new">Acetylseco hemicholinium-3</span></li>
<li><span class="new">Acryloylcholine</span></li>
<li><span class="new">AF64A</span></li>
<li><span class="new">B115</span></li>
<li><span class="new">BETA</span></li>
<li><span class="new">CM-54,903</span></li>
<li><span class="new">N,N-Dimethylaminoethylacrylate</span></li>
<li><span class="new">N,N-Dimethylaminoethylchloroacetate</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center;"><abbr>AChE</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Inhibitors:</b> <i>Reversible:</i> Carbamates: <a href="Aldicarb.htm" tppabs="https://ptable.com/wiki/compounds/A/Aldicarb" title="Aldicarb">Aldicarb</a></li>
<li>Aminocarb</li>
<li><a href="Bendiocarb.htm" tppabs="https://ptable.com/wiki/compounds/A/Bendiocarb" title="Bendiocarb">Bendiocarb</a></li>
<li><span class="new">Bufencarb</span></li>
<li><a href="Carbaryl.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbaryl" title="Carbaryl">Carbaryl</a></li>
<li><a href="Carbendazim.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbendazim" title="Carbendazim">Carbendazim</a></li>
<li><span class="new">Carbetamide</span></li>
<li><a href="Carbofuran.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbofuran" title="Carbofuran">Carbofuran</a></li>
<li>Carbosulfan</li>
<li><span class="new">Chlorbufam</span></li>
<li><span class="new">Chloropropham</span></li>
<li><a href="Dimetilan.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimetilan" title="Dimetilan">Dimetilan</a></li>
<li>Ethienocarb</li>
<li>Ethiofencarb</li>
<li>Fenobucarb</li>
<li><a href="Formetanate.htm" tppabs="https://ptable.com/wiki/compounds/A/Formetanate" title="Formetanate">Formetanate</a></li>
<li>Formparanate</li>
<li><a href="Methiocarb.htm" tppabs="https://ptable.com/wiki/compounds/A/Methiocarb" title="Methiocarb">Methiocarb</a></li>
<li><a href="Methomyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Methomyl" title="Methomyl">Methomyl</a></li>
<li><a href="Metolcarb.htm" tppabs="https://ptable.com/wiki/compounds/A/Metolcarb" title="Metolcarb">Metolcarb</a></li>
<li>Miotine</li>
<li><a href="Oxamyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxamyl" title="Oxamyl">Oxamyl</a></li>
<li><span class="new">Phenmedipham</span></li>
<li><span class="new">Pinmicarb</span></li>
<li><a href="Pirimicarb.htm" tppabs="https://ptable.com/wiki/compounds/A/Pirimicarb" title="Pirimicarb">Pirimicarb</a></li>
<li>Propamocarb</li>
<li><span class="new">Propham</span></li>
<li><a href="Propoxur.htm" tppabs="https://ptable.com/wiki/compounds/A/Propoxur" title="Propoxur">Propoxur</a></li>
<li>Thiofanox; Stigmines: Distigmine</li>
<li><span class="new">Eptastigmine</span></li>
<li><span class="new">Ganstigmine</span></li>
<li><a href="Neostigmine.htm" tppabs="https://ptable.com/wiki/compounds/A/Neostigmine" title="Neostigmine">Neostigmine</a></li>
<li><span class="new">Phenserine</span></li>
<li><a href="Physostigmine.htm" tppabs="https://ptable.com/wiki/compounds/A/Physostigmine" title="Physostigmine">Physostigmine</a></li>
<li><a href="Pyridostigmine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pyridostigmine" title="Pyridostigmine">Pyridostigmine</a></li>
<li><span class="new">Quilostigmine</span></li>
<li><a href="Rivastigmine.htm" tppabs="https://ptable.com/wiki/compounds/A/Rivastigmine" title="Rivastigmine">Rivastigmine</a></li>
<li><span class="new">Terestigmine</span>; Others: Acotiamide</li>
<li><a href="Ambenonium_chloride.htm" tppabs="https://ptable.com/wiki/compounds/A/Ambenonium" title="Ambenonium" class="mw-redirect">Ambenonium</a></li>
<li><a href="Caffeine.htm" tppabs="https://ptable.com/wiki/compounds/A/Caffeine" title="Caffeine">Caffeine</a></li>
<li><a href="Donepezil.htm" tppabs="https://ptable.com/wiki/compounds/A/Donepezil" title="Donepezil">Donepezil</a></li>
<li>EA-3990</li>
<li>EA-4056</li>
<li><a href="Edrophonium.htm" tppabs="https://ptable.com/wiki/compounds/A/Edrophonium" title="Edrophonium">Edrophonium</a></li>
<li><a href="Galantamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Galantamine" title="Galantamine">Galantamine</a></li>
<li>Huperzine A</li>
<li>Ipidacrine</li>
<li>Itopride</li>
<li>Ladostigil</li>
<li><a href="Minaprine.htm" tppabs="https://ptable.com/wiki/compounds/A/Minaprine" title="Minaprine">Minaprine</a></li>
<li>Octamethylene-bis(5-dimethylcarbamoxyisoquinolinium bromide)</li>
<li>T-1123</li>
<li>TL-599</li>
<li>TL-1238</li>
<li><a href="Tacrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tacrine" title="Tacrine">Tacrine</a></li>
<li><span class="new">Zanapezil</span></li></ul>

<ul><li><i>Irreversible:</i> Organophosphates: 2-Ethoxycarbonyl-1-methylvinyl cyclohexyl methylphosphonate</li>
<li><a href="Acephate.htm" tppabs="https://ptable.com/wiki/compounds/A/Acephate" title="Acephate">Acephate</a></li>
<li>Guanitoxin</li>
<li>Armine</li>
<li><a href="Azinphos-ethyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Azinphos-ethyl" title="Azinphos-ethyl">Azinphos-ethyl</a></li>
<li><a href="Azinphos-methyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Azinphos-methyl" title="Azinphos-methyl">Azinphos-methyl</a></li>
<li>BAY-29952</li>
<li><a href="Bensulide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bensulide" title="Bensulide">Bensulide</a></li>
<li><span class="new">Cadusafos</span></li>
<li><a href="Carbophenothion.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbophenothion" title="Carbophenothion">Carbophenothion</a></li>
<li>Chlorethoxyfos</li>
<li><a href="Chlorfenvinphos.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorfenvinphos" title="Chlorfenvinphos">Chlorfenvinphos</a></li>
<li><a href="Chlorpyrifos.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpyrifos" title="Chlorpyrifos">Chlorpyrifos</a></li>
<li><span class="new">Chlorpyrifos-methyl</span></li>
<li><a href="Coumaphos.htm" tppabs="https://ptable.com/wiki/compounds/A/Coumaphos" title="Coumaphos">Coumaphos</a></li>
<li>Crotylsarin</li>
<li><a href="Cyanophos.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyanophos" title="Cyanophos">Cyanophos</a></li>
<li><a href="Cyclosarin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclosarin" title="Cyclosarin">Cyclosarin (GF)</a></li>
<li>Demephion</li>
<li><a href="Demeton.htm" tppabs="https://ptable.com/wiki/compounds/A/Demeton" title="Demeton">Demeton</a></li>
<li><a href="Demeton-S-methyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Demeton-S-methyl" title="Demeton-S-methyl">Demeton-S-methyl</a></li>
<li><a href="Dialifor.htm" tppabs="https://ptable.com/wiki/compounds/A/Dialifor" title="Dialifor">Dialifor</a></li>
<li><a href="Diazinon.htm" tppabs="https://ptable.com/wiki/compounds/A/Diazinon" title="Diazinon">Diazinon</a></li>
<li><a href="Dichlorvos.htm" tppabs="https://ptable.com/wiki/compounds/A/Dichlorvos" title="Dichlorvos">Dichlorvos</a></li>
<li><a href="Dicrotophos.htm" tppabs="https://ptable.com/wiki/compounds/A/Dicrotophos" title="Dicrotophos">Dicrotophos</a></li>
<li><a href="Diisopropyl_fluorophosphate.htm" tppabs="https://ptable.com/wiki/compounds/A/Diisopropyl_fluorophosphate" title="Diisopropyl fluorophosphate">Diisopropyl fluorophosphate</a></li>
<li><a href="Diisopropylphosphate.htm" tppabs="https://ptable.com/wiki/compounds/A/Diisopropylphosphate" title="Diisopropylphosphate">Diisopropylphosphate</a></li>
<li><a href="Dimefox.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimefox" title="Dimefox">Dimefox</a></li>
<li><a href="Dimethoate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimethoate" title="Dimethoate">Dimethoate</a></li>
<li><a href="Dimethyl_4-(methylthio)phenyl_phosphate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimethyl_4-(methylthio)phenyl_phosphate" title="Dimethyl 4-(methylthio)phenyl phosphate">Dimethyl 4-(methylthio)phenyl phosphate</a></li>
<li><a href="Dioxathion.htm" tppabs="https://ptable.com/wiki/compounds/A/Dioxathion" title="Dioxathion">Dioxathion</a></li>
<li><a href="Disulfoton.htm" tppabs="https://ptable.com/wiki/compounds/A/Disulfoton" title="Disulfoton">Disulfoton</a></li>
<li>EA-2012</li>
<li>EA-2054</li>
<li>EA-2098</li>
<li>EA-2192</li>
<li>EA-2613</li>
<li>EA-3148</li>
<li>EA-4352</li>
<li><a href="Echothiophate.htm" tppabs="https://ptable.com/wiki/compounds/A/Echothiophate" title="Echothiophate">Echothiophate</a></li>
<li>Ethylsarin (GE)</li>
<li><a href="Endothion.htm" tppabs="https://ptable.com/wiki/compounds/A/Endothion" title="Endothion">Endothion</a></li>
<li><a href="Ethion.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethion" title="Ethion">Ethion</a></li>
<li><a href="Ethoprop.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethoprop" title="Ethoprop" class="mw-redirect">Ethoprop</a></li>
<li><a href="Fenamiphos.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenamiphos" title="Fenamiphos">Fenamiphos</a></li>
<li><a href="Fenitrothion.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenitrothion" title="Fenitrothion">Fenitrothion</a></li>
<li><a href="Fenthion.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenthion" title="Fenthion">Fenthion</a></li>
<li>Fluorotabun</li>
<li><a href="Fonofos.htm" tppabs="https://ptable.com/wiki/compounds/A/Fonofos" title="Fonofos">Fonofos</a></li>
<li><a href="Formothion.htm" tppabs="https://ptable.com/wiki/compounds/A/Formothion" title="Formothion">Formothion</a></li>
<li><span class="new">Fosthiazate</span></li>
<li>GD-42</li>
<li>GH</li>
<li><span class="new">GT-45</span></li>
<li>GV</li>
<li>Hexaethyl tetraphosphate</li>
<li><a href="Diisopropyl_fluorophosphate.htm" tppabs="https://ptable.com/wiki/compounds/A/Isofluorophate" title="Isofluorophate" class="mw-redirect">Isofluorophate</a></li>
<li><a href="Isoxathion.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoxathion" title="Isoxathion">Isoxathion</a></li>
<li><a href="Leptophos.htm" tppabs="https://ptable.com/wiki/compounds/A/Leptophos" title="Leptophos">Leptophos</a></li>
<li><a href="Malaoxon.htm" tppabs="https://ptable.com/wiki/compounds/A/Malaoxon" title="Malaoxon">Malaoxon</a></li>
<li><a href="Malathion.htm" tppabs="https://ptable.com/wiki/compounds/A/Malathion" title="Malathion">Malathion</a></li>
<li><a href="Methamidophos.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamidophos" title="Methamidophos">Methamidophos</a></li>
<li><a href="Methidathion.htm" tppabs="https://ptable.com/wiki/compounds/A/Methidathion" title="Methidathion">Methidathion</a></li>
<li><a href="Methyl_phenkapton.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyl_phenkapton" title="Methyl phenkapton">Methyl phenkapton</a></li>
<li>Methylfluorophosphonylcholine (MFPCh)</li>
<li><a href="Metrifonate.htm" tppabs="https://ptable.com/wiki/compounds/A/Metrifonate" title="Metrifonate">Metrifonate</a></li>
<li><a href="Mevinphos.htm" tppabs="https://ptable.com/wiki/compounds/A/Mevinphos" title="Mevinphos">Mevinphos</a></li>
<li>Mipafox</li>
<li><a href="Monocrotophos.htm" tppabs="https://ptable.com/wiki/compounds/A/Monocrotophos" title="Monocrotophos">Monocrotophos</a></li>
<li><a href="Naled.htm" tppabs="https://ptable.com/wiki/compounds/A/Naled" title="Naled">Naled</a></li>
<li>Novichok agent</li>
<li><a href="Omethoate.htm" tppabs="https://ptable.com/wiki/compounds/A/Omethoate" title="Omethoate">Omethoate</a></li>
<li>Oxydemeton-methyl</li>
<li><a href="Paraoxon.htm" tppabs="https://ptable.com/wiki/compounds/A/Paraoxon" title="Paraoxon">Paraoxon</a></li>
<li><a href="Parathion.htm" tppabs="https://ptable.com/wiki/compounds/A/Parathion" title="Parathion">Parathion</a></li>
<li>Parathion-methyl</li>
<li><a href="Phorate.htm" tppabs="https://ptable.com/wiki/compounds/A/Phorate" title="Phorate">Phorate</a></li>
<li><a href="Phosalone.htm" tppabs="https://ptable.com/wiki/compounds/A/Phosalone" title="Phosalone">Phosalone</a></li>
<li><a href="Phosfolan.htm" tppabs="https://ptable.com/wiki/compounds/A/Phosfolan" title="Phosfolan">Phosfolan</a></li>
<li><a href="Phosmet.htm" tppabs="https://ptable.com/wiki/compounds/A/Phosmet" title="Phosmet">Phosmet</a></li>
<li><a href="Phosphamidon.htm" tppabs="https://ptable.com/wiki/compounds/A/Phosphamidon" title="Phosphamidon">Phosphamidon</a></li>
<li><a href="Phoxim.htm" tppabs="https://ptable.com/wiki/compounds/A/Phoxim" title="Phoxim">Phoxim</a></li>
<li>Pirimiphos-methyl</li>
<li>Profenofos</li>
<li>Prothoate</li>
<li><span class="new">Ro 3-0340</span></li>
<li><span class="new">Ro 3-0346</span></li>
<li><span class="new">Ro 3-0347</span></li>
<li><span class="new">Ro 3-0351</span></li>
<li><span class="new">Ro 3-0352</span></li>
<li><span class="new">Ro 3-0397</span></li>
<li><span class="new">Ro 3-0411</span></li>
<li>Ro 3-0412</li>
<li><span class="new">Ro 3-0417</span></li>
<li>Ro 3-0419</li>
<li>Ro 3-0422</li>
<li><span class="new">Ro 3-0433</span></li>
<li><a href="Sarin.htm" tppabs="https://ptable.com/wiki/compounds/A/Sarin" title="Sarin">Sarin (GB)</a></li>
<li>Schradan</li>
<li><a href="Soman.htm" tppabs="https://ptable.com/wiki/compounds/A/Soman" title="Soman">Soman (GD)</a></li>
<li><a href="Tabun_(nerve_agent).htm" tppabs="https://ptable.com/wiki/compounds/A/Tabun_(nerve_agent)" title="Tabun (nerve agent)">Tabun (GA)</a></li>
<li>Tebupirimfos</li>
<li><a href="Temefos.htm" tppabs="https://ptable.com/wiki/compounds/A/Temefos" title="Temefos">Temefos</a></li>
<li>Terbufos</li>
<li>Tetrachlorvinphos</li>
<li><a href="Tetraethyl_pyrophosphate.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetraethyl_pyrophosphate" title="Tetraethyl pyrophosphate">Tetraethyl pyrophosphate</a></li>
<li>Triazofos</li>
<li><span class="new">Tribufos</span></li>
<li><a href="Metrifonate.htm" tppabs="https://ptable.com/wiki/compounds/A/Trichlorfon" title="Trichlorfon" class="mw-redirect">Trichlorfon</a></li>
<li>Trichloronate</li>
<li><a href="Tricresyl_phosphate.htm" tppabs="https://ptable.com/wiki/compounds/A/Tricresyl_phosphate" title="Tricresyl phosphate">Tricresyl phosphate</a></li>
<li>VE</li>
<li><a href="VG_(nerve_agent).htm" tppabs="https://ptable.com/wiki/compounds/A/VG_(nerve_agent)" title="VG (nerve agent)">VG</a></li>
<li>VM</li>
<li>VP</li>
<li>VS</li>
<li>VR</li>
<li>VX; Others: Demecarium</li>
<li>Fasciculins (green mamba toxins) (<span class="new">1</span>, <span class="new">2</span>, <span class="new">3</span>, <span class="new">4</span>)</li>
<li>Onchidal (<i>Onchidella binneyi</i>)</li>
<li><a href="Methanesulfonyl_fluoride.htm" tppabs="https://ptable.com/wiki/compounds/A/Methanesulfonyl_fluoride" title="Methanesulfonyl fluoride">Methanesulfonyl fluoride</a></li></ul>

<ul><li><i>Unsorted:</i> α-Pinene</li>
<li>α-Viniferin</li>
<li>Affinine</li>
<li>Affinisine</li>
<li>Arisugacin A</li>
<li>Bulbocapnine</li>
<li>Conodurine</li>
<li>Coronaridine</li>
<li>Corydaline</li>
<li>Corynoline</li>
<li><a href="Crimidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Crimidine" title="Crimidine">Crimidine</a></li>
<li>Cyclanoline</li>
<li>Cymserine</li>
<li><a href="Harmaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Harmaline" title="Harmaline">Harmaline</a></li>
<li>Kobophenol A</li>
<li>Lactucopicrin</li>
<li>Lycorine</li>
<li>Phosacetim</li>
<li><a href="Rosmarinic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Rosmarinic_acid" title="Rosmarinic acid">Rosmarinic acid</a></li>
<li>Stercuronium iodide</li>
<li>Taspine</li>
<li><a href="Tetrahydrocannabinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrahydrocannabinol" title="Tetrahydrocannabinol">Tetrahydrocannabinol</a></li>
<li>Ungeremine</li>
<li>Ungiminorine</li>
<li>Dimethylcarbamoyl fluoride</li>
<li>BW284C51</li>
<li>TMTFA</li></ul>

<ul><li><b>Reactivators:</b> Asoxime chloride</li>
<li><span class="new">Methoxime</span></li>
<li><a href="Obidoxime.htm" tppabs="https://ptable.com/wiki/compounds/A/Obidoxime" title="Obidoxime">Obidoxime</a></li>
<li><a href="Pralidoxime.htm" tppabs="https://ptable.com/wiki/compounds/A/Pralidoxime" title="Pralidoxime">Pralidoxime</a></li>
<li>Trimedoxime bromide</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center;"><abbr>BChE</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Inhibitors:</b> Affinine</li>
<li>Affinisine</li>
<li>Conodurine</li>
<li>Cymserine</li>
<li>Ladostigil</li>
<li><a href="Profenamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Profenamine" title="Profenamine">Profenamine (ethopropazine)</a></li>
<li><a href="Rivastigmine.htm" tppabs="https://ptable.com/wiki/compounds/A/Rivastigmine" title="Rivastigmine">Rivastigmine</a></li>
<li><a href="Tacrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tacrine" title="Tacrine">Tacrine</a></li>
<li><span class="new">ZINC-12613047</span></li>
<li>Many of the other AChE inhibitors listed above</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Transporter<br><small>(modulators)</small></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center;"><abbr>CHT</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Inhibitors:</b> Hemicholinium-3 (hemicholine)</li>
<li>Triethylcholine</li></ul>

<ul><li><b>Enhancers:</b> Coluracetam</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center;"><abbr>VAChT</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Inhibitors:</b> Vesamicol</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Release<br><small>(modulators)</small></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center;">Inhibitors</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b><abbr>SNAP-25</abbr> inactivators:</b> <a href="Botulinum_toxin.htm" tppabs="https://ptable.com/wiki/compounds/A/Botulinum_toxin" title="Botulinum toxin">Botulinum toxin</a> (A, <span class="new">C</span>, <span class="new">E</span>)</li></ul>

<ul><li><b><abbr>VAMP</abbr> inactivators:</b> <a href="Botulinum_toxin.htm" tppabs="https://ptable.com/wiki/compounds/A/Botulinum_toxin" title="Botulinum toxin">Botulinum toxin</a> (<span class="new">B</span>, <span class="new">D</span>, <span class="new">F</span>, <span class="new">G</span>)</li></ul>

<ul><li><b>Others:</b> Bungarotoxins (β-bungarotoxin, γ-bungarotoxin)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center;">Enhancers</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b><abbr>LPHN</abbr> agonists:</b> α-Latrotoxin</li></ul>

<ul><li><b>Others:</b> Atracotoxins (e.g., robustoxin, <span class="new">versutoxin</span>)</li>
<li>Crotoxin</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div><i><b>See also:</b> Receptor/signaling modulators • Muscarinic acetylcholine receptor modulators • Nicotinic acetylcholine receptor modulators</i></div></td></tr></tbody></table></div><span>
</span>
<div role="navigation" class="navbox" aria-labelledby="Nicotinic_acetylcholine_receptor_modulators" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Nicotinic_acetylcholine_receptor_modulators" style="font-size:114%;margin:0 4em">Nicotinic acetylcholine receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>nAChRs</abbr></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Agonists<br>(and <abbr>PAMs</abbr>)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="5-Hydroxyindoleacetic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/5-Hydroxyindoleacetic_acid" title="5-Hydroxyindoleacetic acid">5-HIAA</a></li>
<li>A-84,543</li>
<li>A-366,833</li>
<li><span class="new">A-582,941</span></li>
<li><span class="new">A-867,744</span></li>
<li>ABT-202</li>
<li>ABT-418</li>
<li><span class="new">ABT-560</span></li>
<li><span class="new">ABT-894</span></li>
<li><a href="Acetylcholine.htm" tppabs="https://ptable.com/wiki/compounds/A/Acetylcholine" title="Acetylcholine">Acetylcholine</a></li>
<li>Altinicline</li>
<li><a href="Anabasine.htm" tppabs="https://ptable.com/wiki/compounds/A/Anabasine" title="Anabasine">Anabasine</a></li>
<li><a href="Anatoxin-a.htm" tppabs="https://ptable.com/wiki/compounds/A/Anatoxin-a" title="Anatoxin-a">Anatoxin-a</a></li>
<li>AR-R17779</li>
<li><a href="Bephenium_hydroxynaphthoate.htm" tppabs="https://ptable.com/wiki/compounds/A/Bephenium_hydroxynaphthoate" title="Bephenium hydroxynaphthoate">Bephenium hydroxynaphthoate</a></li>
<li>Butinoline</li>
<li>Butyrylcholine</li>
<li><a href="Carbachol.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbachol" title="Carbachol">Carbachol</a></li>
<li><a href="Choline.htm" tppabs="https://ptable.com/wiki/compounds/A/Choline" title="Choline">Choline</a></li>
<li><a href="Cotinine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cotinine" title="Cotinine">Cotinine</a></li>
<li><a href="Cytisine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cytisine" title="Cytisine">Cytisine</a></li>
<li><a href="Decamethonium.htm" tppabs="https://ptable.com/wiki/compounds/A/Decamethonium" title="Decamethonium">Decamethonium</a></li>
<li>Desformylflustrabromine</li>
<li>Dianicline</li>
<li>Dimethylphenylpiperazinium</li>
<li>Epibatidine</li>
<li>Epiboxidine</li>
<li>Ethanol (alcohol)</li>
<li><span class="new">Ethoxysebacylcholine</span></li>
<li><span class="new">EVP-4473</span></li>
<li>EVP-6124</li>
<li><a href="Galantamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Galantamine" title="Galantamine">Galantamine</a></li>
<li>GTS-21</li>
<li>Ispronicline</li>
<li><a href="Ivermectin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ivermectin" title="Ivermectin">Ivermectin</a></li>
<li>JNJ-39393406</li>
<li><a href="Levamisole.htm" tppabs="https://ptable.com/wiki/compounds/A/Levamisole" title="Levamisole">Levamisole</a></li>
<li>Lobeline</li>
<li><span class="new">MEM-63,908 (RG-3487)</span></li>
<li>Morantel</li>
<li><a href="Nicotine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotine" title="Nicotine">Nicotine</a> (tobacco)</li>
<li><span class="new">NS-1738</span></li>
<li>PHA-543,613</li>
<li><span class="new">PHA-709,829</span></li>
<li>PNU-120,596</li>
<li>PNU-282,987</li>
<li>Pozanicline</li>
<li><a href="Pyrantel.htm" tppabs="https://ptable.com/wiki/compounds/A/Pyrantel" title="Pyrantel">Pyrantel</a></li>
<li>Rivanicline</li>
<li>RJR-2429</li>
<li>Sazetidine A</li>
<li>SB-206553</li>
<li><span class="new">Sebacylcholine</span></li>
<li><span class="new">SIB-1508Y</span></li>
<li>SIB-1553A</li>
<li>SSR-180,711</li>
<li><span class="new">Suberyldicholine</span></li>
<li><a href="Suxamethonium_chloride.htm" tppabs="https://ptable.com/wiki/compounds/A/Suxamethonium" title="Suxamethonium" class="mw-redirect">Suxamethonium (succinylcholine)</a></li>
<li>Suxethonium (succinyldicholine)</li>
<li>TC-1698</li>
<li><span class="new">TC-1734</span></li>
<li>TC-1827</li>
<li>TC-2216</li>
<li><a href="Mecamylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/TC-5214" title="TC-5214" class="mw-redirect">TC-5214</a></li>
<li>TC-5619</li>
<li><span class="new">TC-6683</span></li>
<li>Tebanicline</li>
<li>Tribendimidine</li>
<li>Tropisetron</li>
<li>UB-165</li>
<li><a href="Varenicline.htm" tppabs="https://ptable.com/wiki/compounds/A/Varenicline" title="Varenicline">Varenicline</a></li>
<li>WAY-317,538</li>
<li><span class="new">XY-4083</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Antagonists<br>(and <abbr>NAMs</abbr>)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>18-MAC</li>
<li>18-MC</li>
<li>α-Neurotoxins (e.g., α-bungarotoxin, α-cobratoxin, α-conotoxin, many others)</li>
<li><span class="new">ABT-126</span></li>
<li>Alcuronium</li>
<li><a href="Allopregnanolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Allopregnanolone" title="Allopregnanolone">Allopregnanolone</a></li>
<li><a href="Amantadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amantadine" title="Amantadine">Amantadine</a></li>
<li><span class="new">Anatruxonium</span></li>
<li><span class="new">AQW051</span></li>
<li>Atracurium</li>
<li><a href="Barbiturate.htm" tppabs="https://ptable.com/wiki/compounds/A/Barbiturates" title="Barbiturates" class="mw-redirect">Barbiturates</a> (e.g., <a href="Pentobarbital.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentobarbital" title="Pentobarbital">pentobarbital</a>, <a href="Sodium_thiopental.htm" tppabs="https://ptable.com/wiki/compounds/A/Sodium_thiopental" title="Sodium thiopental">sodium thiopental</a>)</li>
<li>BNC-210</li>
<li>Bungarotoxins (e.g., α-bungarotoxin, κ-bungarotoxin)</li>
<li><a href="Bupropion.htm" tppabs="https://ptable.com/wiki/compounds/A/Bupropion" title="Bupropion">Bupropion</a></li>
<li>BW284C51</li>
<li>BW-A444</li>
<li>Candocuronium iodide (chandonium iodide)</li>
<li>Chlorisondamine</li>
<li>Cisatracurium</li>
<li>Coclaurine</li>
<li>Coronaridine</li>
<li>Curare</li>
<li><a href="Cyclopropane.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclopropane" title="Cyclopropane">Cyclopropane</a></li>
<li>Dacuronium bromide</li>
<li><a href="Decamethonium.htm" tppabs="https://ptable.com/wiki/compounds/A/Decamethonium" title="Decamethonium">Decamethonium</a></li>
<li>Dehydronorketamine</li>
<li><a href="Desflurane.htm" tppabs="https://ptable.com/wiki/compounds/A/Desflurane" title="Desflurane">Desflurane</a></li>
<li><a href="Dextromethorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextromethorphan" title="Dextromethorphan">Dextromethorphan</a></li>
<li><a href="Dextropropoxyphene.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextropropoxyphene" title="Dextropropoxyphene">Dextropropoxyphene</a></li>
<li>Dextrorphan</li>
<li><span class="new">Diadonium</span></li>
<li><span class="new">DHβE</span></li>
<li>Dihydrochandonium</li>
<li>Dimethyltubocurarine (metocurine)</li>
<li>Dioscorine</li>
<li>Dipyrandium</li>
<li>Dizocilpine (MK-801)</li>
<li>Doxacurium</li>
<li>Encenicline</li>
<li><a href="Enflurane.htm" tppabs="https://ptable.com/wiki/compounds/A/Enflurane" title="Enflurane">Enflurane</a></li>
<li>Erythravine</li>
<li>Esketamine</li>
<li>Fazadinium</li>
<li><a href="Gallamine_triethiodide.htm" tppabs="https://ptable.com/wiki/compounds/A/Gallamine" title="Gallamine" class="mw-redirect">Gallamine</a></li>
<li>Gantacurium chloride</li>
<li><a href="Halothane.htm" tppabs="https://ptable.com/wiki/compounds/A/Halothane" title="Halothane">Halothane</a></li>
<li><a href="Hexafluronium_bromide.htm" tppabs="https://ptable.com/wiki/compounds/A/Hexafluronium" title="Hexafluronium" class="mw-redirect">Hexafluronium</a></li>
<li><a href="Hexamethonium.htm" tppabs="https://ptable.com/wiki/compounds/A/Hexamethonium" title="Hexamethonium">Hexamethonium (benzohexonium)</a></li>
<li>Hydroxybupropion</li>
<li>Hydroxynorketamine</li>
<li>Ibogaine</li>
<li><a href="Isoflurane.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoflurane" title="Isoflurane">Isoflurane</a></li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a></li>
<li><a href="Kynurenic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Kynurenic_acid" title="Kynurenic acid">Kynurenic acid</a></li>
<li><a href="Laudanosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Laudanosine" title="Laudanosine">Laudanosine</a></li>
<li>Laudexium (laudolissin)</li>
<li><a href="Levacetylmethadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levacetylmethadol" title="Levacetylmethadol">Levacetylmethadol</a></li>
<li>Levomethadone</li>
<li>Malouetine</li>
<li>ME-18-MC</li>
<li><a href="Mecamylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mecamylamine" title="Mecamylamine">Mecamylamine</a></li>
<li><a href="Memantine.htm" tppabs="https://ptable.com/wiki/compounds/A/Memantine" title="Memantine">Memantine</a></li>
<li><a href="Methadone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methadone" title="Methadone">Methadone</a></li>
<li><a href="Methorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Methorphan" title="Methorphan">Methorphan (racemethorphan)</a></li>
<li>Methyllycaconitine</li>
<li><a href="Metocurine.htm" tppabs="https://ptable.com/wiki/compounds/A/Metocurine" title="Metocurine">Metocurine</a></li>
<li><a href="Mivacurium_chloride.htm" tppabs="https://ptable.com/wiki/compounds/A/Mivacurium" title="Mivacurium" class="mw-redirect">Mivacurium</a></li>
<li>Morphanol (racemorphan)</li>
<li>Neramexane</li>
<li><a href="Nitrous_oxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrous_oxide" title="Nitrous oxide">Nitrous oxide</a></li>
<li>Norketamine</li>
<li><a href="Pancuronium_bromide.htm" tppabs="https://ptable.com/wiki/compounds/A/Pancuronium_bromide" title="Pancuronium bromide">Pancuronium bromide</a></li>
<li><a href="Pempidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pempidine" title="Pempidine">Pempidine</a></li>
<li>Pentamine</li>
<li>Pentolinium</li>
<li><a href="Phencyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phencyclidine" title="Phencyclidine">Phencyclidine</a></li>
<li><a href="Pipecuronium_bromide.htm" tppabs="https://ptable.com/wiki/compounds/A/Pipecuronium_bromide" title="Pipecuronium bromide">Pipecuronium bromide</a></li>
<li><a href="Progesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Progesterone" title="Progesterone">Progesterone</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Promegestone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Promegestone'" tppabs="https://ptable.com/wiki/compounds/A/Promegestone" title="Promegestone">Promegestone</a></li>
<li>Radafaxine</li>
<li>Rapacuronium bromide</li>
<li><a href="Reboxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Reboxetine" title="Reboxetine">Reboxetine</a></li>
<li><a href="Rocuronium_bromide.htm" tppabs="https://ptable.com/wiki/compounds/A/Rocuronium_bromide" title="Rocuronium bromide">Rocuronium bromide</a></li>
<li><a href="Sevoflurane.htm" tppabs="https://ptable.com/wiki/compounds/A/Sevoflurane" title="Sevoflurane">Sevoflurane</a></li>
<li>Stercuronium iodide</li>
<li>Surugatoxin</li>
<li>Thiocolchicoside</li>
<li>Toxiferine</li>
<li><a href="Tramadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tramadol" title="Tramadol">Tramadol</a></li>
<li><a href="Trimetaphan_camsilate.htm" tppabs="https://ptable.com/wiki/compounds/A/Trimetaphan_camsilate" title="Trimetaphan camsilate">Trimetaphan camsilate (trimethaphan camsylate)</a></li>
<li><span class="new">Tropeinium</span></li>
<li>Tubocurarine</li>
<li><a href="Vanoxerine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vanoxerine" title="Vanoxerine">Vanoxerine</a></li>
<li><a href="Vecuronium_bromide.htm" tppabs="https://ptable.com/wiki/compounds/A/Vecuronium_bromide" title="Vecuronium bromide">Vecuronium bromide</a></li>
<li><a href="Xenon.htm" tppabs="https://ptable.com/wiki/compounds/A/Xenon" title="Xenon">Xenon</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Precursors<br><small>(and prodrugs)</small></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Acetyl-coA</li>
<li>Adafenoxate</li>
<li><a href="Choline.htm" tppabs="https://ptable.com/wiki/compounds/A/Choline" title="Choline">Choline</a> (<a href="Lecithin.htm" tppabs="https://ptable.com/wiki/compounds/A/Lecithin" title="Lecithin">lecithin</a>)</li>
<li><a href="Citicoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Citicoline" title="Citicoline">Citicoline</a></li>
<li>Cyprodenate</li>
<li><a href="Dimethylethanolamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimethylethanolamine" title="Dimethylethanolamine">Dimethylethanolamine</a></li>
<li>Glycerophosphocholine</li>
<li>Meclofenoxate (centrophenoxine)</li>
<li><a href="Phosphatidylcholine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phosphatidylcholine" title="Phosphatidylcholine">Phosphatidylcholine</a></li>
<li><a href="Phosphatidylethanolamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phosphatidylethanolamine" title="Phosphatidylethanolamine">Phosphatidylethanolamine</a></li>
<li>Phosphorylcholine</li>
<li>Pirisudanol</li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div><i><b>See also:</b> Receptor/signaling modulators • Muscarinic acetylcholine receptor modulators • Acetylcholine metabolism/transport modulators</i></div></td></tr></tbody></table></div><span>
</span>












<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-08-06" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Galantamine&oldid=971458746  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Galantamine&oldid=971458746'" tppabs="https://en.wikipedia.org/wiki/?title=Galantamine&oldid=971458746">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>